Literature DB >> 17975778

Bronchoalveolar lavage in occupational lung diseases.

Carlos Robalo Cordeiro1, Jessica Cemlyn Jones, Tiago Alfaro, António Jorge Ferreira.   

Abstract

Occupational lung diseases (OLDs) are related to the exposure and inhalation of organic, inorganic, and synthetic particles, fumes, gases, or infectious agents. From the long list of OLDs this article focuses the discussion on bronchoalveolar lavage (BAL) in parenchymal immunoinflammatory conditions, such as hypersensitivity pneumonitis (HP) and pneumoconiosis. Several antigens may cause HP, including products of plant or animal origin, aerosolized microorganisms, and organic chemicals. BAL is used not only to assess the pathogenesis of these diseases but also to identify the typical pattern of intense lymphocytic alveolitis, usually with a CD4:CD8 ratio below normal and frequently with the presence of mast cells, plasma cells, and foamy macrophages. Pneumoconioses are chronic interstitial lung diseases caused by the inhalation of mineral and metallic inorganic particles/dusts in an occupational setting, showing a decreasing prevalence in recent years. BAL is a useful tool not only to express the complex pathogenic mechanisms of these entities but also in excluding other diagnoses and causes of alveolitis, and to document specific exposures, such as the identification of asbestos bodies (ABs) in asbestosis or the proliferative response of BAL lymphocytes to beryllium in chronic beryllium disease (CBD).

Entities:  

Mesh:

Year:  2007        PMID: 17975778     DOI: 10.1055/s-2007-991523

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  14 in total

1.  Bronchoalveolar lavage cell pattern from healthy human lung.

Authors:  M Heron; J C Grutters; K M ten Dam-Molenkamp; D Hijdra; A van Heugten-Roeling; A M E Claessen; H J T Ruven; J M M van den Bosch; H van Velzen-Blad
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

2.  Activated CD8(+) T cells and NKT cells in BAL fluid improve diagnostic accuracy in sarcoidosis.

Authors:  A Tøndell; A D Rø; A Åsberg; M Børset; T Moen; M Sue-Chu
Journal:  Lung       Date:  2013-11-10       Impact factor: 2.584

Review 3.  Bronchoalveolar lavage and other methods to define the human respiratory tract milieu in health and disease.

Authors:  Herbert Y Reynolds
Journal:  Lung       Date:  2011-02-25       Impact factor: 2.584

4.  Genetic variability of T cell responses in hypersensitivity pneumonitis identified using the BXD genetic reference panel.

Authors:  Jin Wang; Tae Won Yoon; Robert Read; Ae-Kyung Yi; Robert W Williams; Elizabeth A Fitzpatrick
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-01-15       Impact factor: 5.464

5.  Coal Mine Dust Desquamative Chronic Interstitial Pneumonia: A Precursor of Dust-Related Diffuse Fibrosis and of Emphysema.

Authors:  Tomislav M Jelic; Oscar C Estalilla; Phyllis R Sawyer-Kaplan; Milton J Plata; Jeremy T Powers; Mary Emmett; John T Kuenstner
Journal:  Int J Occup Environ Med       Date:  2017-07

6.  Hypersensitivity pneumonitis: an overlooked cause of cough and dyspnea.

Authors:  Ryan S D'souza; Anthony Donato
Journal:  J Community Hosp Intern Med Perspect       Date:  2017-06-06

Review 7.  A reconsideration of acute Beryllium disease.

Authors:  Kristin J Cummings; Aleksandr B Stefaniak; M Abbas Virji; Kathleen Kreiss
Journal:  Environ Health Perspect       Date:  2009-04-28       Impact factor: 9.031

8.  Management of hypersensivity pneumonitis.

Authors:  Ioana O Agache; Liliana Rogozea
Journal:  Clin Transl Allergy       Date:  2013-02-04       Impact factor: 5.871

9.  Clinical case: Differential diagnosis of idiopathic pulmonary fibrosis.

Authors:  Carlos Robalo Cordeiro; Tiago M Alfaro; Sara Freitas
Journal:  BMC Res Notes       Date:  2013-04-16

10.  Bronchoalveolar Lavage Fluid Characteristics of Patients With Sarcoidosis and Nonsarcoidosis Interstitial Lung Diseases: Ten-Year Experience of a Single Center in Turkey.

Authors:  Hakan Tanriverdi; Fatma Erboy; Bulent Altinsoy; Firat Uygur; Mehmet Arasli; Ishak Ozel Tekin; Muge Meltem Tor; Figen Atalay
Journal:  Iran Red Crescent Med J       Date:  2015-10-28       Impact factor: 0.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.